Overview
EN ISO 20031:2022 (ISO 20031:2020) - titled Radiological protection - Monitoring and dosimetry for internal exposures due to wound contamination with radionuclides - defines requirements for monitoring, assessment and recordkeeping when radioactive material contaminates a wound. Adopted by CEN in 2022, this standard covers both direct (in vivo) wound-site measurements and systemic (in vitro) bioassay monitoring to assess local and committed internal doses after a wound contamination event.
The document sets out the purpose and structure of special monitoring programmes for wound contamination, performance criteria for radiobioassay, procedures for local and systemic dose assessment, uncertainty analysis, quality assurance, and reporting requirements.
Key topics and technical requirements
- Scope of monitoring: Requirements for in vivo wound measurements at the contaminated site and systemic monitoring to detect radionuclide uptake.
- Dose assessment: Procedures to estimate local (wound-site) dose and systemic (committed) dose, including the impact of medical interventions (e.g., excision, chelation, decorporation).
- Data collection: Essential information to characterise the wound and the radioactive contaminant (wound type, contaminant category).
- Radiobioassay performance criteria: Minimum expectations for in vitro measurements, measurement quality and uncertainty considerations.
- Uncertainty and QA: Guidance on quantifying uncertainties in local and internal dose estimates and establishing quality assurance programs for monitoring and dosimetry.
- Documentation & reporting: Requirements for recording measurement results, treatment waste, dose assessment documentation and final reports.
- Supportive tools and references: Use of software tools for bioassay data interpretation; annexes provide wound-model parameters, dose coefficients and examples (e.g., NCRP wound model, IDEAS guidelines).
Note: The standard does not specify detailed monitoring methods for individual radionuclides, address monitoring of materials on intact skin or pre-existing wounds (including hot particles), nor provide therapeutic protocols - though responsible entities must consider decontamination and decorporation where appropriate.
Applications and users
EN ISO 20031:2022 is intended for:
- Radiation protection professionals and health physicists designing wound-contamination monitoring programmes.
- Occupational safety teams in nuclear, medical isotope production, research labs and industrial settings.
- Emergency responders and medical personnel involved in initial care and follow-up of contaminated wounds.
- Dosimetry laboratories and regulators responsible for dose assessment, quality assurance and reporting.
Practical uses include establishing procedural workflows for wound monitoring, implementing bioassay strategies, estimating local and committed effective doses, and documenting compliance with radiological protection practices.
Related standards and references
- NCRP wound model (referenced in Annex A)
- IDEAS Guidelines for estimation of committed doses from incorporation monitoring (referenced)
- Annex F: committed effective dose coefficients for selected radionuclides
Keywords: EN ISO 20031:2022, radiological protection, wound contamination, internal exposure, dosimetry, monitoring, radionuclides, bioassay, in vivo, in vitro, dose assessment.